-
Forward Look
Your Neighborhood, YourselfQ&A with Reginald Tucker-Seeley on the link between neighborhoods and cancer.
by Sue Rochman
-
From the Editor-in-Chief
Inheritance, ‘Bad Luck’ and the EnvironmentWhy do some people develop cancer while others do not?
by William G. Nelson, MD, PhD
-
Forward Look
There Goes the NeighborhoodQ&A with scientist Zena Werb on cancer, immunity and the microenvironment.
by Chris Palmer
-
Forward Look
Cost of Breast Cancer Treatment Affects AdherenceDrug for early-stage cancer must be taken for many years to be effective.
by Kendall K. Morgan
-
Forward Look
Cancer Treatment Can Reactivate Hepatitis BResearchers make the case for screening cancer patients for hepatitis B before treatment.
by Yasmine Iqbal
-
Forward Look
First Biosimilar Drug Approved in U.S.New drugs will offer same effectiveness, but at a lower cost.
by Stephen Ornes
-
The DCIS Dilemma
Ductal carcinoma in situ is the fourth most common cancer diagnosis in women. Some say it's not "really" cancer. But you wouldn't know that based on how it is treated.
by Sue Rochman
-
Healthy Habits
Reaping the BenefitsFollowing a vegetarian diet could reduce your risk of colorectal cancer.
by Leigh Labrie
-
Q&A
The Language of CancerResearcher David J. Hauser discusses how war metaphors may make people less likely to engage in preventive behaviors.
by Sharlene George
Cancer Talk
Understanding How High and Low Testosterone Levels Can Treat Prostate Cancer
Using high-dose testosterone after prostate cancer stops responding to androgen deprivation therapy can stop tumor growth.
by Sandra Gordon
Financial Screenings for People with CancerCancer patients say they want to be asked about their financial needs on a regular basis.
by Pamela Appea
Let Me Tell You a Story About the Power of Medical ResearchTen-year-old Michael Methner told his story about being diagnosed with optic nerve glioma at the AACR’s Rally for Medical Research.
by Cancer Research Catalyst
Aggressive Approach to Very Advanced Cancer Does Not Extend SurvivalStudy shows no benefit from treatment for cancers at very advanced stages of progression. Researchers urge end-of-life planning for these patients.
by Kyle Bagenstose